Table 2 Mean scores on patient-reported outcome measures at each study time point.

From: Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Domain

Baseline

Na

Mean (SD)

3 months

Na

Mean (SD)

6 months

Na

Mean (SD)

12 months

Na

Mean (SD)

24 months

Na

Mean (SD)

36 months

Na

Mean (SD)

48 months

Na

Mean (SD)

60 months

Na

Mean (SD)

Physical Function

320

51.5 (8.3)

282

52 (8.1)

253

53.3 (7.9)

214

53.2 (8.1)

144

53.9 (8.1)

91

54.5 (7.6)

52

54.3 (7.3)

24

56.8 (8.1)

Endocrine Symptoms

319

65.1 (8.6)

281

63.7 (8.8)

252

63.7 (8.4)

214

62.5 (9.4)

143

62.9 (8.9)

90

63.4 (8.1)

52

63.4 (8.2)

24

67.2 (7.5)

Sexual Problems

315

27.4 (32.0)

277

27.9 (33.7)

248

25.8 (31.4)

210

27.1 (31.1)

141

25.2 (30.2)

90

21.6 (28)

51

25.3 (30.1)

23

20.4 (29.8)

Depression

319

45.4 (7.8)

280

44.9 (8.1)

250

44.6 (8)

212

45.2 (8.1)

142

44.2 (8.2)

91

43.5 (7.8)

52

44.9 (6.3)

24

43.0 (7.6)

Anxiety

320

49.0 (9.4)

281

47.9 (9.1)

253

47.5 (8.7)

214

48.1 (8.6)

144

47.4 (8.4)

91

47.3 (8.5)

52

47.6 (7.5)

24

43.8 (7.5)

Sleep Disturbance

320

49.0 (8.1)

282

49.8 (8.7)

253

48.8 (8.3)

215

49.1 (8.65)

144

47.6 (8.3)

91

49 (7.8)

52

46.8 (9)

24

43.8 (7.5)

Fatigue

319

48.7 (7.7)

281

48.3 (7.9)

252

48 (8.5)

215

47.3 (8.3)

146

46.4 (8.9)

90

46.6 (7.5)

52

46.1 (7.9)

24

43.3 (5.9)

Pain Interference

319

48.4 (8.2)

281

47.7 (8.2)

252

46.8 (7.6)

214

47.4 (7.5)

143

47.3 (7.7)

90

46 (6.7)

52

45.8 (7.4)

24

44.4 (5.6)

  1. SD standard deviation.
  2. a N at each time point for each domain represents the number of participants who completed the patient-reported outcome measure.